Biolex Biolex has a production platform for protein drugs that uses transgenic plants. They recently filed papers with the SEC for an IPO. Here is a partial list of relevant posts: <a href='read_msg.asp?message_id=23627540'>#msg-23627540</a> Locteron phase-2a data <a href='read_msg.asp?message_id=22069017'>#msg-22069017</a> IPO filing <a href='read_msg.asp?message_id=21229000'>#msg-21229000</a> BLX-155 preclinical data <a href='read_msg.asp?message_id=19450622'>#msg-19450622</a> Collaboration with Genmab <a href='read_msg.asp?message_id=15116312'>#msg-15116312</a> Homogeneity of glycosylation <a href='read_msg.asp?message_id=5919466'>#msg-5919466</a> ‘Plantibody’ patent